Dan Conlon, VP of Business Development, and Stefania Colarusso, Senior Research Investigator, will be attending the USA TIDES: Oligonucleotides and Peptide Therapeutics event next week. As part of the conference's agenda, Stefania will be delivering a talk entitled: "An appropriate…
From May 14th-16th, Matteo Liguori, Managing Director, and Heidi Kingdon Jones, Global VP of Sales and Marketing, will be in Tel Aviv for MIXiii-Biomed. The event is billed as the main healthcare meeting in Israel, attracting key stakeholders from around the world to explore…
On May 7th, Pier Giorgio Pacifici, our Business Development Manager, will be in Basel attending Swiss Biotech Day 2019. The event brings together leading biotechnological and pharmaceutical researchers, analysts, stakeholders, decision makers and more to discuss their innovations within these…
Our Global VP of Sales and Marketing, Heidi Kingdon Jones, is attending BioTrinity Europe in London from April 30th to May 1st. Now in its 13th year, BioTrinity is Europe's leading biopartnering and investment conference. Get in touch to organize…
We're gearing up for the World Vaccine Congress, which is being held in Washington D.C. from April 14th to 17th. Having run for nearly two decades, the conference demonstrates how innovative research can be integrated into Pharma, academia and policy,…
We will be the EASL International Liver Congress from April 10th to 14th in Vienna. The annual event welcomes leading scientific and medical experts to explore cutting-edge developments in fields allied to hepatology. Vincenzo Summa, VP of Drug Development, and…
Our Director of High Throughput Biology and Screening, Alberto Bresciani, will be attending the European IN Cell User Meeting from April 8th-9th in Mannheim, Germany. The two-day event features an interesting range of talks, and is organized by GE Healthcare.…
The American Association for Cancer Research Annual Meeting is being held from March 29th to April 3rd in Atlanta, Georgia. The event highlights the transformative work being undertaken across the broad spectrum of cancer research from organizations worldwide. Carlo Toniatti,…
Pier Giorgio Pacifici, Ph.D., IRBM’s Business Development Manager, and Stefania Di Marco, PhD, QP at IRBM’s GMP-compliant adenoviral-based vaccine manufacturing facility ADVENT, will be attending the International Conference on Vaccines and Immunization in Rome on March 21st-22nd. The event unites…
On March 21-22, Simone Esposito (Research Scientist) will be attending 5th European Bioanalysis Forum YYS in Bologna, Italy. To learn more about how IRBM can support your drug discovery, drop us a line to request a meeting!